Gene Therapy Shows Long-Term Vision Benefits in Rare Eye Disease

Watchdoq December 22, 2024
(MedPage Today) -- Patients with Leber hereditary optic neuropathy (LHON) due to the MT-ND4 gene variant treated with the gene therapy lenadogene nolparvovec in one eye showed a sustained improvement in best-corrected visual acuity (BCVA) in both...

Read Full Article